Antibody Response to IR sub(6), a Conserved Immunodominant Region of the VlsE Lipoprotein, Wanes Rapidly after Antibiotic Treatment of Borrelia burgdorferi Infection in Experimental Animals and in Humans

Invariable region (IR) sub(6), an immunodominant conserved region of VlsE, the antigenic variation protein of Borrelia burgdorferi, is currently used for the serologic diagnosis of Lyme disease in humans and canines. A longitudinal assessment of anti-IR sub(6) antibody levels in B. burgdorferi-infec...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 184; no. 7; pp. 870 - 878
Main Authors Philipp, M T, Bowers, L C, Fawcett, P T, Jacobs, M B, Liang, F T, Marques, A R, Mitchell, P D, Purcell, JE, Ratterree, MS, Straubinger, R K
Format Journal Article
LanguageEnglish
Published 01.10.2001
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Invariable region (IR) sub(6), an immunodominant conserved region of VlsE, the antigenic variation protein of Borrelia burgdorferi, is currently used for the serologic diagnosis of Lyme disease in humans and canines. A longitudinal assessment of anti-IR sub(6) antibody levels in B. burgdorferi-infected rhesus monkeys revealed that this level diminished sharply after antibiotic treatment (within 25 weeks). In contrast, antibody levels to P39 and to whole-cell antigen extracts of B. burgdorferi either remained unchanged or diminished less. A longitudinal analysis in dogs yielded similar results. In humans, the anti-IR sub(6) antibody titer diminished by a factor of greater than or equal to 4 in successfully treated patients and by a factor of <4 in treatment-resistant patients. This result suggests that the quantification of anti-IR sub(6) antibody titer as a function of time should be investigated further as a test to assess response to Lyme disease therapy or to determine whether a B. burgdorferi infection has been eliminated.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Feature-1
ISSN:0022-1899